WisdomTree Chinese Yuan ... (AMEX:CYB)
Historical Stock Chart
From Jan 2020 to Jan 2025
Cybex International, Inc. (AMEX: CYB), a leading exercise equipment
manufacturer, today reported results for the third quarter ended
September 30, 2006. Net sales for the third quarter 2006 were
$29,849,000, compared to $26,690,000 for the third quarter 2005, an
increase of 12%. On a GAAP basis, the Company reported net income for
the third quarter of 2006 of $817,000, or $.05 per diluted share,
compared to a net loss of $3,535,000, or $(.23) per diluted share, for
the corresponding period of 2005. Excluding a third quarter 2005
litigation-related charge, and after an adjustment to the tax provision
as described below, the Company’s third
quarter 2005 non-GAAP net income was $346,000, or $.02 per diluted share.
For the nine months ended September 30, 2006, net sales were
$88,712,000, compared to $78,646,000 for 2005, an increase of 13%. On a
GAAP basis, the Company reported net income for the nine months ended
September 30, 2006 of $17,592,000, or $1.05 per diluted share, compared
to a net loss of $2,378,000, or $(.16) per diluted share, for the
corresponding period of 2005. Excluding a second quarter 2006 reduction
of the valuation reserve for deferred taxes and the third quarter 2005
litigation-related charge, and after adjustments to the Company’s
tax provision for each period as described below, the Company’s
non-GAAP net income for the nine months ended September 30, 2006 was
$2,287,000, or $.14 per diluted share, compared to non-GAAP net income
of $1,073,000, or $.07 per diluted share, for the corresponding 2005
period.
Actual GAAP results for the nine months ended September 30, 2006,
include a $14,421,000 reduction in the Company’s
deferred tax valuation reserve, resulting in a net tax benefit of
$13,735,000 for the nine months ended September 30, 2006. Actual GAAP
results for the third quarter and nine months ended September 24, 2005
included an increase in the Company’s
litigation reserve resulting in a pre-tax charge of $4,101,000. This
increase in the litigation reserve reflected the jury verdict in a
patent infringement case and the reversal on appeal of a summary
judgment in favor of the Company in another patent infringement case.
The Company’s appeal of the jury verdict is
pending and it continues to vigorously defend the other patent
infringement suit which has since returned to the trial level.
The Company’s deferred tax valuation reserve
was reduced effective July 1, 2006, and the GAAP results for the quarter
and nine months ended September 30, 2006 include a third quarter 2006
tax provision reflecting an effective tax rate of approximately 41%. The
2006 non-GAAP results include a tax provision calculated as though the
Company’s effective tax rate for the third
quarter 2006 was applicable for all of the first nine months of 2006,
while the 2005 non-GAAP results include a tax provision at approximately
the same effective rate. The non-GAAP adjustments have been made to
provide a basis for reviewing the Company’s
operating performance on a consistent basis for all of the periods
presented.
John Aglialoro, Chairman and CEO, stated, “We
are excited about our re-entry into the high-end consumer market with
our recent introduction of our Consumer Arc Trainer. The Company is
aggressively advancing our new product development pace and CYBEX is
poised for an exciting new product line-up for 2007.”
Cybex International, Inc. is a leading manufacturer of premium exercise
equipment for commercial and consumer use. The CYBEX product line
includes a full range of both strength training and cardio training
machines sold worldwide under the CYBEX brand. Products and programs are
designed and engineered to reflect the natural movement of the human
body, assisting each unique user – from the
professional athlete to the first-time exerciser –
to improve daily human performance. For more information on CYBEX and
its product line, please visit the Company’s
website at www.cybexinternational.com.
This news release may contain forward-looking statements. There
are a number of risks and uncertainties that could cause actual results
to differ materially from those anticipated by the statements made above.
These include, but are not limited to, competitive factors,
technological and product developments, market demand, economic
conditions, the resolution of litigation involving the Company, and the
ability of the Company to comply with the terms of its credit facilities.
Further information on these and other factors which could affect the
Company’s financial results can be found in
the Company’s previously filed Report on Form
10-K, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its
proxy statement dated April 4, 2006.
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - ACTUAL
(In thousands, except per share data)
(unaudited)
Three Months Ended
Nine Months Ended
September 30,
September 24,
September 30,
September 24,
2006
2005
2006
2005
Net sales
$
29,849
$
26,690
$
88,712
$
78,646
Cost of sales
19,269
17,143
56,719
50,593
Gross profit
10,580
9,547
31,993
28,053
As a percentage of sales
35.4%
35.8%
36.1%
35.7%
Selling, general and administrative expenses
9,052
8,276
26,973
24,325
Litigation charges
--
4,101
--
4,101
Operating income (loss)
1,528
(2,830)
5,020
(373)
Interest expense, net
150
679
1,163
1,894
Income (loss) before income taxes
1,378
(3,509)
3,857
(2,267)
Income tax provision (benefit)
561
26
(13,735)
111
Net income (loss)
$
817
$
(3,535)
$
17,592
$
(2,378)
Basic net income (loss) per share
$
.05
$
(.23)
$
1.09
$
(.16)
Diluted net income (loss) per share
$
.05
$
(.23)
$
1.05
$
(.16)
Shares used in computing basic net income (loss) per share
17,185
15,130
16,128
15,119
Shares used in computing diluted net income (loss) per share
17,807
15,130
16,794
15,119
CYBEX INTERNATIONAL, INC.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(In thousands, except per share data)
(unaudited)
Three Months Ended
Nine Months Ended
September 30, 2006
September 24, 2005
September 30, 2006
September 24, 2005
GAAP net income (loss)
$ 817
$ (3,535)
$ 17,592
$ (2,378)
Adjustments
Income tax provision
--
(220)
(15,305)
(650)
Litigation charges
--
4,101
--
4,101
Non-GAAP net income
$ 817
346
$ 2,287
$ 1,073
Basic net income (loss) per share
$ .05
$ (.23)
$ 1.09
$ (.16)
Adjustments
--
.25
(.95)
.23
Non-GAAP basic net income per share
$ .05
$ .02
$ .14
$ .07
Diluted net income (loss) per
share
$ .05
$(.23)
$1.05
$(.16)
Adjustments
--
.25
(.91)
.23
Non-GAAP diluted net income per share
$ .05
$ .02
$ .14
$ .07
Shares used in computing basic net income per share
17,185
15,130
16,128
15,119
Shares used in computing diluted net income per share
17,807
15,715
16,794
15,710
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(unaudited)
September 30, 2006
December 31, 2005
ASSETS
Current assets:
Cash
$
2,327
$
807
Accounts receivable, net
15,174
18,320
Inventories
9,791
9,258
Prepaid expenses and other
3,319
2,707
Deferred tax asset
4,140
--
Total current assets
34,751
31,092
Property and equipment, net
12,193
12,124
Goodwill
11,247
11,247
Deferred tax asset
9,699
--
Other assets
1,277
1,209
$
69,167
$
55,672
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current maturities of long-term debt
$
--
$
3,929
Current portion of capital leases
323
481
Accounts payable
6,109
5,918
Accrued expenses
17,468
16,286
Total current liabilities
23,900
26,614
Long-term debt
--
9,730
Capital leases, excluding current portion
120
332
Other liabilities
1,960
2,808
Total liabilities
25,980
39,484
Stockholders’ equity
43,187
16,188
$
69,167
$
55,672
Cybex International, Inc. (AMEX: CYB), a leading exercise
equipment manufacturer, today reported results for the third quarter
ended September 30, 2006. Net sales for the third quarter 2006 were
$29,849,000, compared to $26,690,000 for the third quarter 2005, an
increase of 12%. On a GAAP basis, the Company reported net income for
the third quarter of 2006 of $817,000, or $.05 per diluted share,
compared to a net loss of $3,535,000, or $(.23) per diluted share, for
the corresponding period of 2005. Excluding a third quarter 2005
litigation-related charge, and after an adjustment to the tax
provision as described below, the Company's third quarter 2005
non-GAAP net income was $346,000, or $.02 per diluted share.
For the nine months ended September 30, 2006, net sales were
$88,712,000, compared to $78,646,000 for 2005, an increase of 13%. On
a GAAP basis, the Company reported net income for the nine months
ended September 30, 2006 of $17,592,000, or $1.05 per diluted share,
compared to a net loss of $2,378,000, or $(.16) per diluted share, for
the corresponding period of 2005. Excluding a second quarter 2006
reduction of the valuation reserve for deferred taxes and the third
quarter 2005 litigation-related charge, and after adjustments to the
Company's tax provision for each period as described below, the
Company's non-GAAP net income for the nine months ended September 30,
2006 was $2,287,000, or $.14 per diluted share, compared to non-GAAP
net income of $1,073,000, or $.07 per diluted share, for the
corresponding 2005 period.
Actual GAAP results for the nine months ended September 30, 2006,
include a $14,421,000 reduction in the Company's deferred tax
valuation reserve, resulting in a net tax benefit of $13,735,000 for
the nine months ended September 30, 2006. Actual GAAP results for the
third quarter and nine months ended September 24, 2005 included an
increase in the Company's litigation reserve resulting in a pre-tax
charge of $4,101,000. This increase in the litigation reserve
reflected the jury verdict in a patent infringement case and the
reversal on appeal of a summary judgment in favor of the Company in
another patent infringement case. The Company's appeal of the jury
verdict is pending and it continues to vigorously defend the other
patent infringement suit which has since returned to the trial level.
The Company's deferred tax valuation reserve was reduced effective
July 1, 2006, and the GAAP results for the quarter and nine months
ended September 30, 2006 include a third quarter 2006 tax provision
reflecting an effective tax rate of approximately 41%. The 2006
non-GAAP results include a tax provision calculated as though the
Company's effective tax rate for the third quarter 2006 was applicable
for all of the first nine months of 2006, while the 2005 non-GAAP
results include a tax provision at approximately the same effective
rate. The non-GAAP adjustments have been made to provide a basis for
reviewing the Company's operating performance on a consistent basis
for all of the periods presented.
John Aglialoro, Chairman and CEO, stated, "We are excited about
our re-entry into the high-end consumer market with our recent
introduction of our Consumer Arc Trainer. The Company is aggressively
advancing our new product development pace and CYBEX is poised for an
exciting new product line-up for 2007."
Cybex International, Inc. is a leading manufacturer of premium
exercise equipment for commercial and consumer use. The CYBEX product
line includes a full range of both strength training and cardio
training machines sold worldwide under the CYBEX brand. Products and
programs are designed and engineered to reflect the natural movement
of the human body, assisting each unique user - from the professional
athlete to the first-time exerciser - to improve daily human
performance. For more information on CYBEX and its product line,
please visit the Company's website at www.cybexinternational.com.
This news release may contain forward-looking statements. There
are a number of risks and uncertainties that could cause actual
results to differ materially from those anticipated by the statements
made above. These include, but are not limited to, competitive
factors, technological and product developments, market demand,
economic conditions, the resolution of litigation involving the
Company, and the ability of the Company to comply with the terms of
its credit facilities. Further information on these and other factors
which could affect the Company's financial results can be found in the
Company's previously filed Report on Form 10-K, its Reports on Form
10-Q, its Current Reports on Form 8-K, and its proxy statement dated
April 4, 2006.
-0-
*T
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - ACTUAL
(In thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
------------------- -------------------
September September September September
30, 24, 30, 24,
2006 2005 2006 2005
--------- --------- --------- ---------
Net sales $29,849 $26,690 $ 88,712 $78,646
Cost of sales 19,269 17,143 56,719 50,593
--------- --------- --------- ---------
Gross profit 10,580 9,547 31,993 28,053
As a percentage of sales 35.4% 35.8% 36.1% 35.7%
Selling, general and
administrative expenses 9,052 8,276 26,973 24,325
Litigation charges -- 4,101 -- 4,101
--------- --------- --------- ---------
Operating income (loss) 1,528 (2,830) 5,020 (373)
Interest expense, net 150 679 1,163 1,894
--------- --------- --------- ---------
Income (loss) before income
taxes 1,378 (3,509) 3,857 (2,267)
Income tax provision
(benefit) 561 26 (13,735) 111
--------- --------- --------- ---------
Net income (loss) $ 817 $(3,535) $ 17,592 $(2,378)
========= ========= ========= =========
Basic net income (loss) per
share $ .05 $ (.23) $ 1.09 $ (.16)
========= ========= ========= =========
Diluted net income (loss) per
share $ .05 $ (.23) $ 1.05 $ (.16)
========= ========= ========= =========
Shares used in computing
basic net income (loss) per
share 17,185 15,130 16,128 15,119
========= ========= ========= =========
Shares used in computing
diluted net income (loss)
per share 17,807 15,130 16,794 15,119
========= ========= ========= =========
*T
-0-
*T
CYBEX INTERNATIONAL, INC.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(In thousands, except per share data)
(unaudited)
Three Months Ended Nine Months Ended
------------------------ -----------------------
September 30, September September 30, September
2006 24, 2005 2006 24, 2005
-------------- --------- ------------- ---------
GAAP net income
(loss) $817 $(3,535) $17,592 $(2,378)
Adjustments
Income tax
provision -- (220) (15,305) (650)
Litigation
charges -- 4,101 -- 4,101
-------------- --------- ------------- ---------
Non-GAAP net income $817 346 $2,287 $1,073
============== ========= ============= =========
Basic net income
(loss) per share $.05 $(.23) $1.09 $(.16)
Adjustments -- .25 (.95) .23
-------------- --------- ------------- ---------
Non-GAAP basic net
income per share $.05 $.02 $.14 $.07
============== ========= ============= =========
Diluted net income
(loss) per
share $.05 $(.23) $1.05 $(.16)
Adjustments -- .25 (.91) .23
-------------- --------- ------------- ---------
Non-GAAP diluted net
income per share $.05 $.02 $.14 $.07
============== ========= ============= =========
Shares used in
computing basic net
income per share 17,185 15,130 16,128 15,119
============== ========= ============= =========
Shares used in
computing diluted
net income per
share 17,807 15,715 16,794 15,710
============== ========= ============= =========
*T
-0-
*T
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(unaudited)
September 30, December 31,
2006 2005
-------------- ---------------
ASSETS
Current assets:
Cash $ 2,327 $ 807
Accounts receivable, net 15,174 18,320
Inventories 9,791 9,258
Prepaid expenses and other 3,319 2,707
Deferred tax asset 4,140 --
-------------- ---------------
Total current assets 34,751 31,092
Property and equipment, net 12,193 12,124
Goodwill 11,247 11,247
Deferred tax asset 9,699 --
Other assets 1,277 1,209
-------------- ---------------
$69,167 $55,672
============== ===============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current maturities of long-term debt $ -- $ 3,929
Current portion of capital leases 323 481
Accounts payable 6,109 5,918
Accrued expenses 17,468 16,286
-------------- ---------------
Total current liabilities 23,900 26,614
Long-term debt -- 9,730
Capital leases, excluding current
portion 120 332
Other liabilities 1,960 2,808
-------------- ---------------
Total liabilities 25,980 39,484
Stockholders' equity 43,187 16,188
-------------- ---------------
$69,167 $55,672
============== ===============
*T